| Product Code: ETC6663559 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Patented Drugs Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Patented Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Patented Drugs Market - Industry Life Cycle |
3.4 Canada Patented Drugs Market - Porter's Five Forces |
3.5 Canada Patented Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.6 Canada Patented Drugs Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.7 Canada Patented Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Canada Patented Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development by pharmaceutical companies |
4.2.2 Rising prevalence of chronic diseases driving demand for innovative patented drugs |
4.3 Market Restraints |
4.3.1 Stringent regulatory processes for drug approval |
4.3.2 Growing competition from generic drug manufacturers |
5 Canada Patented Drugs Market Trends |
6 Canada Patented Drugs Market, By Types |
6.1 Canada Patented Drugs Market, By Distribution Channel |
6.1.1 Overview and Analysis |
6.1.2 Canada Patented Drugs Market Revenues & Volume, By Distribution Channel, 2021- 2031F |
6.1.3 Canada Patented Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.1.4 Canada Patented Drugs Market Revenues & Volume, By Drug Store and Retail Pharmacies, 2021- 2031F |
6.1.5 Canada Patented Drugs Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.2 Canada Patented Drugs Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 Canada Patented Drugs Market Revenues & Volume, By Solid Drug Product, 2021- 2031F |
6.2.3 Canada Patented Drugs Market Revenues & Volume, By Liquid Drug Product, 2021- 2031F |
6.2.4 Canada Patented Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Canada Patented Drugs Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Canada Patented Drugs Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.3.3 Canada Patented Drugs Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.4 Canada Patented Drugs Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.3.5 Canada Patented Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Canada Patented Drugs Market Import-Export Trade Statistics |
7.1 Canada Patented Drugs Market Export to Major Countries |
7.2 Canada Patented Drugs Market Imports from Major Countries |
8 Canada Patented Drugs Market Key Performance Indicators |
8.1 Research and development expenditure as a percentage of total revenue for pharmaceutical companies |
8.2 Number of patents filed for new drugs in Canada |
8.3 Average time taken for drug approval process in Canada |
8.4 Percentage of market share held by generic drug manufacturers |
8.5 Adoption rate of newly launched patented drugs in the Canadian market |
9 Canada Patented Drugs Market - Opportunity Assessment |
9.1 Canada Patented Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.2 Canada Patented Drugs Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.3 Canada Patented Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Canada Patented Drugs Market - Competitive Landscape |
10.1 Canada Patented Drugs Market Revenue Share, By Companies, 2024 |
10.2 Canada Patented Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here